Category Archives : VOLUME 9 ISSUE 5

Modern patients are taking control of their own healthcare, from sharing information with one another to approaching industry organisations with their concerns. Tarquin Scadding-Hunt at mdgroup discusses how, in order to appeal to this new wave of patient-consumers, clinical trial ...

A revolution is happening in the healthcare industry. Societal pressure to improve our health, technological advances, and market forces are all driving forward a novel patient-centric approach to healthcare. Tim Davis of ERT discusses how putting the patient first can ...

Integration and increased automation are transforming the way life sciences companies manage much of their operational and regulatory information. Labelling and packaging content – so critical to market acceptance and patient safety – remain subject to very separate, manual processes, ...

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the same time as there are major changes happening in the research and development of highvalue and often potent ...

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge at PAREXEL International explain that, while there is no single transformative solution to streamline clinical ...